ScholarLens Back to search
2000•European Journal of PharmacologyRequires access

Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes

Yasunori Tsubouchi, Hajime Sano, Ryoji Yamada, Akira Hashiramoto, Masataka Kohno, Yoshiaki Kusaka, Motoharu Kondo

Open publisher page 13 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 13 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Meloxicam, Cyclooxygenase, Chemistry, Prostaglandin E2, Western blot, Pharmacology, Rheumatoid arthritis, Internal medicine

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes — Research Paper | ScholarLens